Emmaus Life Sciences, Inc. (EMMA) stock
EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05−0.01 (-14.38%)
Close on Oct 19, 2026Market cap $6.03MP/E –Yield –
Emmaus Life Sciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Emmaus Life Sciences's total debt was $800.00K at Dec 31, 2021. For fiscal 2021 it was $800.00K, up 2447.8% from the year before. The highest annual figure on record is $800.00K in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $800.00K | +2447.8% |
| FY2016 | Sep 30, 2016 | $31.40K | +797.1% |
| FY2014 | Sep 30, 2014 | $3.50K | -51.4% |
| FY2013 | Sep 30, 2013 | $7.20K | +38.5% |
| FY2012 | Sep 30, 2012 | $5.20K | -14.8% |
| FY2011 | Sep 30, 2011 | $6.10K | -77.3% |
| FY2010 | Sep 30, 2010 | $26.90K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $800.00K | +4633.7% |
| Q3 FY2019CQ3 2018 | Jun 30, 2019 | $615.80K | +1861.1% |
| Q2 FY2019CQ2 2018 | Mar 31, 2019 | $606.50K | +17738.2% |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $2.00K | -39.4% |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $16.90K | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $31.40K | – |
| Q2 FY2015CQ1 2015 | Mar 31, 2015 | $3.40K | – |
| Q1 FY2015CQ4 2014 | Dec 31, 2014 | $3.30K | – |
See a number that looks wrong?